Home/Filings/4/0000950170-24-015202
4//SEC Filing

THOMA BRAVO FUND X, L.P. 4

Accession 0000950170-24-015202

CIK 0001773383other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:05 PM ET

Size

24.7 KB

Accession

0000950170-24-015202

Insider Transaction Report

Form 4
Period: 2024-02-12
Transactions
  • Sale

    Common Stock

    2024-02-12$52.60/sh14,242,929$749,178,06516,114,344 total(indirect: See footnote)
  • Other

    Common Stock

    2024-02-142,847,72616,114,344 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2024-02-142,847,72616,114,344 total(indirect: See footnote)
  • Sale

    Common Stock

    2024-02-12$52.60/sh14,242,929$749,178,06516,114,344 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2024-02-142,847,72616,114,344 total(indirect: See footnote)
  • Sale

    Common Stock

    2024-02-12$52.60/sh14,242,929$749,178,06516,114,344 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2024-02-142,847,72616,114,344 total(indirect: See footnote)
  • Sale

    Common Stock

    2024-02-12$52.60/sh14,242,929$749,178,06516,114,344 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2024-02-12$52.60/sh14,242,929$749,178,06516,114,344 total(indirect: See footnote)
  • Other

    Common Stock

    2024-02-142,847,72616,114,344 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2024-02-12$52.60/sh14,242,929$749,178,06516,114,344 total(indirect: See footnote)
  • Other

    Common Stock

    2024-02-142,847,72616,114,344 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2024-02-12$52.60/sh14,242,929$749,178,06516,114,344 total(indirect: See footnote)
  • Other

    Common Stock

    2024-02-142,847,72616,114,344 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2024-02-12$52.60/sh14,242,929$749,178,06516,114,344 total(indirect: See footnote)
  • Other

    Common Stock

    2024-02-142,847,72616,114,344 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2024-02-12$52.60/sh14,242,929$749,178,06516,114,344 total(indirect: See footnote)
  • Other

    Common Stock

    2024-02-142,847,72616,114,344 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2024-02-12$52.60/sh14,242,929$749,178,06516,114,344 total(indirect: See footnote)
  • Other

    Common Stock

    2024-02-142,847,72616,114,344 total(indirect: See footnote)
Footnotes (4)
  • [F1]On February 12, 2024, the Reporting Persons sold an aggregate of 14,242,929 shares of the Issuer's Common Stock, par value $0.001 per share, pursuant to Rule 144 under the Securities Act of 1933, as amended.
  • [F2]After giving effect to the distribution reported on this statement, consists of 839,999 shares held directly by Thoma Bravo Fund X, L.P. ("TB Fund X"), 183,745 shares held directly by Thoma Bravo Fund X-A, L.P. ("TB Fund X-A"), 3,956,572 shares held directly by Thoma Bravo Fund XI, L.P. ("TB Fund XI"), 1,987,086 shares held directly by Thoma Bravo Fund XI-A, L.P. ("TB Fund XI-A"), 87,284 shares held directly by Thoma Bravo Executive Fund XI, L.P. ("TB Exec Fund"), 72,073 shares held directly by Thoma Bravo Special Opportunities Fund I, L.P. ("TB SOF"), 530,982 shares held directly by Thoma Bravo Special Opportunities Fund I AIV, L.P. ("TB SOF AIV"), 1,798,578 shares held directly by Thoma Bravo Partners X, L.P. ("TB Partners X"), and 6,658,025 shares held directly by Thoma Bravo Partners XI, L.P. ("TB Partners XI").
  • [F3]Thoma Bravo Partners X, L.P. ("TB Partners X") is the general partner of each of TB Fund X, TB Fund X-A, TB SOF and TB SOF AIV. Thoma Bravo Partners XI, L.P. ("TB Partners XI") is the general partner of each of TB Fund XI, TB Fund XI-A and TB Exec Fund. Thoma Bravo UGP, LLC is the ultimate managing member of TB Partners X and TB Partners XI. By virtue of the relationships described in this footnote, Thoma Bravo UGP, LLC may be deemed to exercise voting and dispositive power with respect to the shares held by TB Fund X, TB Fund X-A, TB SOF, TB SOF AIV, TB Fund XI, TB Fund XI-A and TB Exec Fund. Each of TB Partners X, TB Partners XI and Thoma Bravo UGP, LLC disclaims beneficial ownership of the shares owned by TB Fund X, TB Fund X-A, TB SOF, TB SOF AIV, TB Fund XI, TB Fund XI-A and TB Exec Fund except to the extent of its pecuniary interest therein.
  • [F4]Represents a distribution of (i) 175,612 shares held directly by TB SOF AIV, 24,437 shares held directly by TB SOF, 351,970 shares held directly by TB Fund X and 58,947 shares held directly by TB Fund X-A, in each case to TB Partners X, and (ii) 27,878 shares held directly by TB Exec Fund, 1,607,653 shares held directly by TB Fund XI, and 601,229 shares held directly by TB Fund XI-A, in each case to TB Partners XI.

Documents

1 file

Issuer

Dynatrace, Inc.

CIK 0001773383

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001537211

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:05 PM ET
Size
24.7 KB